BRISTOL-MYERS SQUIBB CO (1BMY.MI) Stock Fundamental Analysis

BIT:1BMY • US1101221083

51.43 EUR
+0.41 (+0.8%)
Last: Feb 16, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Overall 1BMY gets a fundamental rating of 5 out of 10. We evaluated 1BMY against 49 industry peers in the Pharmaceuticals industry. While 1BMY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1BMY is valued quite cheap, but it does not seem to be growing. Finally 1BMY also has an excellent dividend rating. With these ratings, 1BMY could be worth investigating further for value and dividend investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year 1BMY was profitable.
  • In the past year 1BMY had a positive cash flow from operations.
  • Of the past 5 years 1BMY 4 years were profitable.
  • In the past 5 years 1BMY always reported a positive cash flow from operatings.
1BMY.MI Yearly Net Income VS EBIT VS OCF VS FCF1BMY.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.83%, 1BMY is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
  • With an excellent Return On Equity value of 38.19%, 1BMY belongs to the best of the industry, outperforming 90.38% of the companies in the same industry.
  • 1BMY has a Return On Invested Capital of 19.52%. This is amongst the best in the industry. 1BMY outperforms 80.77% of its industry peers.
  • 1BMY had an Average Return On Invested Capital over the past 3 years of 14.47%. This is in line with the industry average of 13.98%.
  • The 3 year average ROIC (14.47%) for 1BMY is below the current ROIC(19.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROIC 19.52%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
1BMY.MI Yearly ROA, ROE, ROIC1BMY.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • 1BMY's Profit Margin of 14.64% is in line compared to the rest of the industry. 1BMY outperforms 57.69% of its industry peers.
  • 1BMY's Profit Margin has improved in the last couple of years.
  • The Operating Margin of 1BMY (35.82%) is better than 88.46% of its industry peers.
  • In the last couple of years the Operating Margin of 1BMY has grown nicely.
  • Looking at the Gross Margin, with a value of 72.63%, 1BMY is in line with its industry, outperforming 59.62% of the companies in the same industry.
  • In the last couple of years the Gross Margin of 1BMY has remained more or less at the same level.
Industry RankSector Rank
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
1BMY.MI Yearly Profit, Operating, Gross Margins1BMY.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1BMY is creating value.
  • The number of shares outstanding for 1BMY has been increased compared to 1 year ago.
  • Compared to 5 years ago, 1BMY has less shares outstanding
  • The debt/assets ratio for 1BMY has been reduced compared to a year ago.
1BMY.MI Yearly Shares Outstanding1BMY.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
1BMY.MI Yearly Total Debt VS Total Assets1BMY.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • 1BMY has an Altman-Z score of 2.55. This is not the best score and indicates that 1BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of 1BMY (2.55) is comparable to the rest of the industry.
  • 1BMY has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as 1BMY would need 3.51 years to pay back of all of its debts.
  • 1BMY's Debt to FCF ratio of 3.51 is fine compared to the rest of the industry. 1BMY outperforms 71.15% of its industry peers.
  • A Debt/Equity ratio of 2.33 is on the high side and indicates that 1BMY has dependencies on debt financing.
  • The Debt to Equity ratio of 1BMY (2.33) is worse than 78.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Altman-Z 2.55
ROIC/WACC2.27
WACC8.58%
1BMY.MI Yearly LT Debt VS Equity VS FCF1BMY.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • 1BMY has a Current Ratio of 1.26. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of 1BMY (1.26) is comparable to the rest of the industry.
  • 1BMY has a Quick Ratio of 1.14. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
  • 1BMY's Quick ratio of 1.14 is fine compared to the rest of the industry. 1BMY outperforms 67.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.14
1BMY.MI Yearly Current Assets VS Current Liabilites1BMY.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • 1BMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 439.47%, which is quite impressive.
  • Measured over the past years, 1BMY shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.92% on average per year.
  • Looking at the last year, 1BMY shows a decrease in Revenue. The Revenue has decreased by -0.22% in the last year.
  • 1BMY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.54% yearly.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%

3.2 Future

  • 1BMY is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.54% yearly.
  • 1BMY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.62% yearly.
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1BMY.MI Yearly Revenue VS Estimates1BMY.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
1BMY.MI Yearly EPS VS Estimates1BMY.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • 1BMY is valuated reasonably with a Price/Earnings ratio of 9.87.
  • Based on the Price/Earnings ratio, 1BMY is valued cheaply inside the industry as 90.38% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, 1BMY is valued rather cheaply.
  • The Price/Forward Earnings ratio is 9.98, which indicates a very decent valuation of 1BMY.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 84.62% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.05, 1BMY is valued rather cheaply.
Industry RankSector Rank
PE 9.87
Fwd PE 9.98
1BMY.MI Price Earnings VS Forward Price Earnings1BMY.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 92.31% of the companies in the same industry are more expensive than 1BMY, based on the Enterprise Value to EBITDA ratio.
  • 1BMY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1BMY is cheaper than 96.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.62
EV/EBITDA 7.39
1BMY.MI Per share data1BMY.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • 1BMY has a very decent profitability rating, which may justify a higher PE ratio.
  • 1BMY's earnings are expected to decrease with -3.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.12%, 1BMY is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.84, 1BMY pays a better dividend. On top of this 1BMY pays more dividend than 86.54% of the companies listed in the same industry.
  • 1BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.12%

5.2 History

  • On average, the dividend of 1BMY grows each year by 6.51%, which is quite nice.
Dividend Growth(5Y)6.51%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1BMY pays out 71.52% of its income as dividend. This is not a sustainable payout ratio.
  • 1BMY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
1BMY.MI Yearly Income VS Free CF VS Dividend1BMY.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B
1BMY.MI Dividend Payout.1BMY.MI Dividend Payout, showing the Payout Ratio.1BMY.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BRISTOL-MYERS SQUIBB CO

BIT:1BMY (2/16/2026, 7:00:00 PM)

51.43

+0.41 (+0.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05
Earnings (Next)04-30
Inst Owners81.87%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap104.70B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.59
Price Target52.72 (2.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.12%
Yearly Dividend2.13
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)7.63%
PT rev (3m)11.64%
EPS NQ rev (1m)1.09%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)0.24%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)3.32%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)6.84%
Revenue NY rev (3m)7.45%
Valuation
Industry RankSector Rank
PE 9.87
Fwd PE 9.98
P/S 2.56
P/FCF 9.62
P/OCF 8.73
P/B 6.69
P/tB N/A
EV/EBITDA 7.39
EPS(TTM)5.21
EY10.13%
EPS(NY)5.15
Fwd EY10.02%
FCF(TTM)5.34
FCFY10.39%
OCF(TTM)5.89
OCFY11.45%
SpS20.05
BVpS7.69
TBVpS-9.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number30.02
Profitability
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROCE 25.91%
ROIC 19.52%
ROICexc 23.22%
ROICexgc 84.94%
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
FCFM 26.65%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Debt/EBITDA 2.03
Cap/Depr 32.69%
Cap/Sales 2.72%
Interest Coverage 8.22
Cash Conversion 66.54%
Profit Quality 182.1%
Current Ratio 1.26
Quick Ratio 1.14
Altman-Z 2.55
F-Score7
WACC8.58%
ROIC/WACC2.27
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.75%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.78%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%

BRISTOL-MYERS SQUIBB CO / 1BMY.MI FAQ

Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?

ChartMill assigns a fundamental rating of 5 / 10 to 1BMY.MI.


Can you provide the valuation status for BRISTOL-MYERS SQUIBB CO?

ChartMill assigns a valuation rating of 7 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.


Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?

BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 7 / 10.


Can you provide the financial health for 1BMY stock?

The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.


Is the dividend of BRISTOL-MYERS SQUIBB CO sustainable?

The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 7 / 10 and the dividend payout ratio is 71.52%.